Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
Melissa Rivers recalled how swiftly the California wildfires spread, forcing the county’s Ready, Set, Go evacuation plan to essentially skip straight to “Set.” That left her with little time to ...
Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans ...
The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...
The CVS Pharmacy at 1498 Opelika Road in Auburn will be closing its doors on Feb. 20, which will leave six remaining CVS ...
Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback